Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 27, 2023

Impact of Metabolic and Bariatric Surgery on MACE in Patients With Severe Obesity and Type 2 Diabetes vs Patients With Type 2 Diabetes Treated With GLP-1 Receptor Agonists

International Journal of Obesity (2005)


Additional Info

International Journal of Obesity (2005)
Major adverse cardiovascular events among patients with type-2 diabetes, a nationwide cohort study comparing primary metabolic and bariatric surgery to GLP-1 receptor agonist treatment
Int J Obes (Lond) 2023 Apr 01;47(4)251-256, E Stenberg, E Näslund

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading